Metabolic genomics

Type 2 Diabetes
& Genetics

Polygenic disease with over 400 known loci. Genetics sets the terrain — lifestyle decides the outcome.

helixXY analyzes variants in TCF7L2, FTO, PPARG, KCNJ11, SLC30A8 and HNF1B — the largest-effect loci for T2D risk, integrated into a polygenic score validated in cohorts of over 1 million people.

Analyze my DNA View analyzed genes
~25%
TCF7L2 carriers
2–4×
Family risk
58%
Lifestyle risk reduction
Sugar shaped like a heart — Type 2 Diabetes & Genetics
6 key genes
+400 loci analyzed
Active prevention
Lifestyle matters
537M
Adults with T2D worldwide
~90%
Of all diabetes cases
~75%
Polygenic heritability
15 min
To receive your complete report
More than high blood sugar

Genetics and environment
in one organism

Type 2 Diabetes is a polygenic, multifactorial disease characterized by progressive insulin resistance and pancreatic beta-cell dysfunction. Unlike Type 1 (autoimmune), T2D involves the interaction between hundreds of small-effect genetic variants and modifiable environmental factors.

Heritability is high — about 75% in twin studies. But clinical expression depends heavily on environment: weight, diet, physical activity, sleep, and stress profoundly modulate disease manifestation even in genetically predisposed people.

helixXY maps the main risk loci and integrates them into a polygenic score (PRS) that stratifies your risk against the population — useful for identifying early who benefits most from preventive interventions.

TCF7L2: the largest-effect gene

The rs7903146 variant in TCF7L2 is the strongest and most replicated genetic risk signal for T2D — present in ~25% of European, African, and Asian populations.

Genetics is not destiny

The Diabetes Prevention Program trial demonstrated that 5–7% weight loss + moderate physical activity reduces risk by 58% — even in people with high genetic load.

Use your existing data

Use your file from 23andMe, Genera, AncestryDNA, etc. Within 15 minutes of upload, your report is ready — no new sample required.

Woman walking in a sunny park

150 minutes per week of moderate activity reduce T2D risk by up to 50% — even in carriers of high genetic load.

Photo by MART PRODUCTION on Pexels

Colorful ratatouille — Mediterranean diet
Diet + DNA = action

400+ loci discovered — and food still speaks louder

GWAS meta-analyses with over 1 million people mapped the T2D atlas. But PREDIMED and DPP studies show: Mediterranean diet and physical activity outperform genetics in prevention.

Photo by Edita Brus on Pexels

Analyzed genes

The 6 largest-effect loci for Type 2 Diabetes

helixXY highlights the largest-effect loci identified in DIAGRAM and MAGIC Consortium meta-analyses — and integrates hundreds of other smaller-effect loci into a polygenic score.

TCF7L2

TCF7L2

Chromosome 10q25.2

Transcription Factor 7-Like 2 — the largest-effect known gene for Type 2 Diabetes in every population studied. The rs7903146 (T-allele) variant impairs insulin secretion from beta cells and affects incretin signaling. Heterozygotes have 1.4× higher risk, homozygotes 2.0× — and ~25% of the population carries at least one copy.

Common variants: rs7903146 (T-allele)rs12255372rs4506565
1.40×
odds ratio per allele
FTO

FTO

Chromosome 16q12.2

Fat Mass and Obesity-associated gene. The rs9939609 (A-allele) variant increases BMI by ~1.5 kg/m² per allele and, indirectly, the risk of Type 2 Diabetes. It encodes an RNA demethylase that regulates appetite control in the hypothalamus. ~16% of Europeans are homozygous.

Common variants: rs9939609 (A-allele)rs1421085rs17817449
1.20×
odds ratio
PPARG

PPARG

Chromosome 3p25.2

Peroxisome Proliferator-Activated Receptor Gamma — a nuclear receptor that regulates adipocyte differentiation and insulin sensitivity. The Pro12Ala variant (rs1801282) is protective: the Ala allele reduces risk by ~15%. Molecular target of thiazolidinediones (pioglitazone).

Common variants: Pro12Ala (rs1801282)rs3856806rs709158
1.14×
odds ratio
KCNJ11

KCNJ11

Chromosome 11p15.1

Kir6.2 subunit of the ATP-sensitive potassium channel, essential for glucose-stimulated insulin secretion. The E23K variant (rs5219) reduces channel sensitivity to ATP, impairing insulin release. Target of sulfonylureas (glibenclamide, gliclazide).

Common variants: E23K (rs5219)rs5215rs5210
1.15×
odds ratio
SLC30A8

SLC30A8

Chromosome 8q24.11

Solute Carrier Family 30 Member 8 — a zinc transporter specific to pancreatic beta cells. Essential for insulin crystallization and storage in secretory granules. Loss-of-function variants protect against T2D (up to 65% reduction in homozygotes for rare variants).

Common variants: R325W (rs13266634)p.Lys34Asnp.Arg138*
1.12×
odds ratio
HNF1B

HNF1B

Chromosome 17q12

Hepatocyte Nuclear Factor 1-Beta. Rare germline variants cause MODY5 (Maturity-Onset Diabetes of the Young, type 5), and common variants moderately increase risk for common T2D. Regulates pancreatic and renal development — explaining associations with renal cysts and urogenital malformations.

Common variants: rs7501939rs4430796rs757210
1.10×
odds ratio

Additional loci also analyzed: The report also includes variants in IGF2BP2, CDKAL1, CDKN2A/B, HHEX, IRS1, JAZF1, MTNR1B, GCK, ADCY5 and more than 400 other loci identified in DIAGRAM Consortium meta-analyses.

Senior man smiling confidently

Photo by Gustavo Fring on Pexels

Aging well

Know early
change earlier

Type 2 Diabetes rarely appears overnight. There's a pre-diabetes phase lasting years — usually asymptomatic, but reversible. Knowing your genetic risk in your 30s–40s lets you adjust weight, diet, and activity while the prevention window is still open.

Studies show each kilogram lost reduces risk by ~16%. Each weekly hour of moderate activity, by ~9%. DNA shows the trend. You decide the trajectory.

How it works

What helixXY delivers

An interpreted, contextualized, and actionable report — not just a list of variants.

Largest-effect loci analysis

Variants in TCF7L2, FTO, PPARG, KCNJ11, SLC30A8 and HNF1B are analyzed based on the most recent DIAGRAM Consortium GWAS.

T2D polygenic risk score

We combine hundreds of loci into a Type 2 Diabetes Polygenic Risk Score (T2D-PRS) validated in cohorts of over 1 million individuals.

Clear clinical context

Each finding comes with literature reference, absolute/relative risk percentages, and contextualization for your age range and ancestry.

Pharmacogenomic insights

Variants in KCNJ11/ABCC8 (sulfonylureas), SLC22A1 (metformin) and PPARG (thiazolidinediones) can inform treatment discussions.

Lifestyle recommendations

Guidance tailored to your genetic risk profile — weight, physical activity, diet, and screening test periodicity.

Absolute privacy

Your data is processed with AES-256 encryption in a zero-knowledge architecture. Full GDPR compliance.

Signs that warrant attention

T2D is often silent for years. In carriers of high genetic risk, attention to subtle signs is essential.

Unexplained fatigue

Persistent tiredness, even after good sleep. Reflects cellular difficulty using glucose for energy.

Thirst and frequent urination

Polyuria and polydipsia appear when blood glucose exceeds the renal threshold (~180 mg/dL). Sign of decompensation.

Acanthosis nigricans

Dark, velvety patches on the neck, armpits, or groin — a classic marker of insulin resistance.

Slow wound healing

Wounds that take long to heal, recurrent infections (urinary, skin, fungal) may indicate chronically elevated blood glucose.

Central obesity

Waist circumference >102 cm (men) or >88 cm (women) is a strong predictor of insulin resistance and T2D.

Pre-diabetes (HbA1c 5.7–6.4%)

A reversible phase with a clear window of opportunity. Detected by routine tests — often the first laboratory evidence.

Grounded in cutting-edge science

Our analysis integrates data from the DIAGRAM Consortium, MAGIC, UK Biobank, and GWAS meta-analyses with over 1 million people — aligned with ADA and EASD guidelines.

Peer-reviewed
DIAGRAM Consortium
ADA / EASD Guidelines
GDPR Compliant

Frequently asked questions

Clear, evidence-based answers about genetics and Type 2 Diabetes.

Important medical notice: The information provided by helixXY is for educational and informational purposes only. It does not constitute a diagnosis, clinical laboratory report, or substitute for medical consultation. Diagnosis of Type 2 Diabetes requires fasting glucose, oral glucose tolerance test, or HbA1c evaluated by an endocrinologist. Always consult a qualified professional.

Knowledge is the best
form of prevention

Upload your genetic file and receive your complete Type 2 Diabetes susceptibility report in under 15 minutes.

Analyze my DNA now View health report

Stay updated and never miss anything.

+1k Join the community

No spam. Cancel anytime.